Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females

University of Connecticut · NCT07365514

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 45–70 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
159
US sites recruiting
1
Study start
July 2026
Record last updated
July 23, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.

Being studied: Blackcurrant (BC) extract; Blackcurrant (BC) extract; Placebo

Conditions: Postmenopausal Osteoporosis; Gut Microbiome; Menopause

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • postmenopausal (defined as no more than 10 years since final menstrual cycle) females aged 45-70 years
  • not on hormone replacement therapy for at least one year before initiation of the study
  • maintaining normal exercise level (\< 7 hours/week) and willing to avoid exercise for 24 hours prior to blood and stool sampling
  • willing to ingest a dietary blackcurrant supplement or placebo (up to 1,176 mg/day, three 392mg capsules)
  • willing to avoid other dietary supplements for the duration of the study
  • willing to avoid intake of foods extremely rich in anthocyanins and fermented dairy products containing viable Bifidobacteria or Lactobacilli
  • willing to have three blood draws, three stool collections, and three bone scans

Exclusion Criteria

  • history of cardiovascular disease, osteoporosis, metabolic bone disease, cancer, diabetes mellitus, arthritis, or other chronic inflammatory diseases
  • current smokers
  • taking prescription medications known to alter bone and calcium metabolism
  • taking anabolic agents such as parathyroid hormone or growth hormone, or steroid within 3 months before the start of the study
  • taking medications that alter bleeding (such as antiplatelets or anticoagulants) or those with a bleeding disorder
  • alcohol consumption exceeding 2 drinks/day (approximately 14g of ethanol per drink) or a total of 12/week
  • those with planned surgery during the study period or within 2 weeks of ending the intervention
  • those with sensitivities or allergies to any of the ingredients for the placebo (rice powder)
  • planning a procedure that includes iodine, barium or nuclear medicine isotopes within the study period
  • UConn students and/or employees who any key personnel teach or who report to any key personnel
  • study key personnel, partners of key personnel, or dependents/relatives of any key personnel

Recruiting US locations

  • University of Connecticut, Department of Nutritional Sciences

    Storrs, CT 06269

    Site contact: Ock Chun, PhD · 860-486-6275 · ock.chun@uconn.edu

Study contacts (from the official record)

  • Ock Chun, PhD · 860-486-6275 · ock.chun@uconn.edu
  • Briana Nosal, MS · 860-878-0679 · briana.nosal@uconn.edu
Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk… (NCT07365514) | Bored Studies